TY - JOUR
T1 - Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body γ-radiation
AU - Li, Jiangwei
AU - Hassan, Ghada S.
AU - Williams, Terence M.
AU - Minetti, Carlo
AU - Pestell, Richard G.
AU - Tanowitz, Herbert B.
AU - Frank, Philippe G.
AU - Sotgia, Federica
AU - Lisanti, Michael P.
N1 - Funding Information:
Caveolin-1 (Cav-1) is a protein marker for caveolae organelles and plays an intricate This work was supported by grants from role in caveolar functioning.13 Cav-1 acts as a scaffolding protein, able to negatively regu-National Institutes of Health (NIH), and the late the activity of several molecules that function along pro-proliferative and pro-survival American Heart Association, as well as pathways. Through a sequence named the Caveolin Scaffolding Domain (CSD, residues Hirschl/Weil-Caulier Career Scientist Award (all 81–101), Cav-1 binds and holds interacting proteins in an inactive state, and releases them to M.P.L.). T.M.W. was supported by a National in a timely fashion upon stimulation.14 Moreover, Cav-1 levels are transcriptionally Institutes of Health Medical Scientist Training reduced upon activation of several oncogenes, including Ha-Ras, v-Abl, Myc, Neu, the Program Grant (T32-GM07288). G.S.H. is a HPV oncogene E6.15-18Therefore, many investigators have proposed the possibility that recipient of post-doctoral fellowships from the Cav-1 is indeed a “tumor suppressor” whose reduction/deletion in cells would provide a Foundation of Health Research (FRSQ), Quebec, growth advantage and expedite tumorigenesis. ©2005 LANDES BIOSCIENCEIn support of a growth suppressor role, Cav-1 deficient mouse embryo fibroblasts (MEFs) were shown to proliferate faster than control cells.19 Concomitant loss of Cav-1 and of another tumor suppressor gene, INK4a, confers even more significant growth advantages upon MEFs, with hyperactivation of the p42/44 MAP kinase cascade and over-expression of Cyclin D1 and PCNA.20While loss of Cav-1 is not sufficient for overt tumor formation, cooperativity with a second oncogenic stimulus is sufficient for tumori-genesis. For example, treatment of Cav-1 deficient skin with the well-known carcinogen DMBA causes severe hyperplasia, and strongly accelerates epidermal tumor formation.21
PY - 2005/12
Y1 - 2005/12
N2 - Caveolin-1 (Cav-1) is a protein marker for caveolae organelles, and acts as a scaffolding protein to negatively regulate the activity of signaling molecules by binding to and releasing them in a timely fashion. We have previously shown that loss of Cav-1 promotes the proliferation of mouse embryo fibroblasts (MEFs) in vitro. Here, to investigate the in vivo relevance of these findings, we evaluated the turnover rates of small intestine crypt stem cells from WT and Cav-1 deficient mice. Interestingly, we show that Cav-1 null crypt stem cells display higher proliferation rates, as judged by BrdU and PCNA staining. In addition, we show that Wnt/β-catenin signaling, which normally controls intestinal stem cell self-renewal, is up-regulated in Cav-1 deficient crypt stem cells. Because the small intestine constitutes one of the main targets of radiation, we next evaluated the role of Cav-1 in radiation-induced damage. Interestingly, after exposure to 15 Gy of γ-radiation, Cav-1 deficient mice displayed a decreased survival rate, as compared to WT mice. Our results show that after radiation treatment, Cav-1 null crypt stem cells of the small intestine exhibit far more apoptosis and accelerated proliferation, leading to a faster depletion of crypts and villi. As a consequence, six days after radiation treatment, Cav-1-/- mice lost all their crypt and villus structures, while WT mice still showed some crypts and intact villi. In summary, we show that ablation of Cav-1 gene expression induces an abnormal amplification of crypt stem cells, resulting in increased susceptibility to γ-radiation. Thus, our studies provide the first evidence that Cav-1 normally regulates the proliferation of intestinal stem cells in vivo.
AB - Caveolin-1 (Cav-1) is a protein marker for caveolae organelles, and acts as a scaffolding protein to negatively regulate the activity of signaling molecules by binding to and releasing them in a timely fashion. We have previously shown that loss of Cav-1 promotes the proliferation of mouse embryo fibroblasts (MEFs) in vitro. Here, to investigate the in vivo relevance of these findings, we evaluated the turnover rates of small intestine crypt stem cells from WT and Cav-1 deficient mice. Interestingly, we show that Cav-1 null crypt stem cells display higher proliferation rates, as judged by BrdU and PCNA staining. In addition, we show that Wnt/β-catenin signaling, which normally controls intestinal stem cell self-renewal, is up-regulated in Cav-1 deficient crypt stem cells. Because the small intestine constitutes one of the main targets of radiation, we next evaluated the role of Cav-1 in radiation-induced damage. Interestingly, after exposure to 15 Gy of γ-radiation, Cav-1 deficient mice displayed a decreased survival rate, as compared to WT mice. Our results show that after radiation treatment, Cav-1 null crypt stem cells of the small intestine exhibit far more apoptosis and accelerated proliferation, leading to a faster depletion of crypts and villi. As a consequence, six days after radiation treatment, Cav-1-/- mice lost all their crypt and villus structures, while WT mice still showed some crypts and intact villi. In summary, we show that ablation of Cav-1 gene expression induces an abnormal amplification of crypt stem cells, resulting in increased susceptibility to γ-radiation. Thus, our studies provide the first evidence that Cav-1 normally regulates the proliferation of intestinal stem cells in vivo.
KW - Apoptosis
KW - Caveolae
KW - Caveolin-1
KW - Crypt stem cells
KW - Intestinal progenitor cells
KW - Proliferation
KW - Radiation treatment
KW - β-catenin
UR - http://www.scopus.com/inward/record.url?scp=29244473885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=29244473885&partnerID=8YFLogxK
U2 - 10.4161/cc.4.12.2199
DO - 10.4161/cc.4.12.2199
M3 - Article
C2 - 16294037
AN - SCOPUS:29244473885
SN - 1538-4101
VL - 4
SP - 1817
EP - 1825
JO - Cell Cycle
JF - Cell Cycle
IS - 12
ER -